These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 26730454

  • 1. Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis.
    Chapel S, Chiu YY, Hsu J, Cucchiaro J, Loebel A.
    Clin Ther; 2016 Jan 01; 38(1):4-15. PubMed ID: 26730454
    [Abstract] [Full Text] [Related]

  • 2. Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.
    Rajagopalan K, Bacci ED, Ng-Mak D, Wyrwich K, Pikalov A, Loebel A.
    BMC Psychiatry; 2016 May 23; 16():157. PubMed ID: 27215976
    [Abstract] [Full Text] [Related]

  • 3. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A, Cucchiaro J, Silva R, Kroger H, Sarma K, Xu J, Calabrese JR.
    Am J Psychiatry; 2014 Feb 23; 171(2):169-77. PubMed ID: 24170221
    [Abstract] [Full Text] [Related]

  • 4. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T, Kroger H, Pikalov A, Loebel A.
    J Psychiatr Res; 2016 Jul 23; 78():86-93. PubMed ID: 27089521
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression: Post Hoc Analysis of 2 Double-Blind, Placebo-Controlled Studies.
    Sajatovic M, Forester BP, Tsai J, Kroger H, Pikalov A, Cucchiaro J, Loebel A.
    J Clin Psychiatry; 2016 Oct 23; 77(10):e1324-e1331. PubMed ID: 27529375
    [Abstract] [Full Text] [Related]

  • 6. Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder.
    Calabrese JR, Pikalov A, Streicher C, Cucchiaro J, Mao Y, Loebel A.
    Eur Neuropsychopharmacol; 2017 Sep 23; 27(9):865-876. PubMed ID: 28689688
    [Abstract] [Full Text] [Related]

  • 7. Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study.
    Forester BP, Sajatovic M, Tsai J, Pikalov A, Cucchiaro J, Loebel A.
    Am J Geriatr Psychiatry; 2018 Feb 23; 26(2):150-159. PubMed ID: 29146409
    [Abstract] [Full Text] [Related]

  • 8. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L, Ketter TA, Cucchiaro J, Loebel A.
    J Affect Disord; 2014 Feb 23; 155():20-7. PubMed ID: 24246116
    [Abstract] [Full Text] [Related]

  • 9. Lurasidone: a review of its use in adult patients with bipolar I depression.
    Sanford M, Dhillon S.
    CNS Drugs; 2015 Mar 23; 29(3):253-63. PubMed ID: 25698146
    [Abstract] [Full Text] [Related]

  • 10. LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY.
    Ketter TA, Sarma K, Silva R, Kroger H, Cucchiaro J, Loebel A.
    Depress Anxiety; 2016 May 23; 33(5):424-34. PubMed ID: 26918425
    [Abstract] [Full Text] [Related]

  • 11. Double-blind, placebo-controlled study of lurasidone monotherapy for the treatment of bipolar I depression.
    Kato T, Ishigooka J, Miyajima M, Watabe K, Fujimori T, Masuda T, Higuchi T, Vieta E.
    Psychiatry Clin Neurosci; 2020 Dec 23; 74(12):635-644. PubMed ID: 32827348
    [Abstract] [Full Text] [Related]

  • 12. Recovery in bipolar depression: Post-hoc analysis of a placebo-controlled lurasidone trial followed by a long-term continuation study.
    Loebel A, Siu C, Rajagopalan K, Pikalov A, Cucchiaro J, Ketter TA.
    J Affect Disord; 2015 Nov 01; 186():376-82. PubMed ID: 26363720
    [Abstract] [Full Text] [Related]

  • 13. Treatment of bipolar depression: making sensible decisions.
    Citrome L.
    CNS Spectr; 2014 Dec 01; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression.
    Rajagopalan K, Meyer K, O'Day K, Denno M, Loebel A.
    J Med Econ; 2015 Dec 01; 18(10):821-7. PubMed ID: 25985265
    [Abstract] [Full Text] [Related]

  • 15. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N, Mullen J, Paulsson B, Vågerö M.
    J Affect Disord; 2007 Dec 01; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [Abstract] [Full Text] [Related]

  • 16. Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial.
    McIntyre RS, Cucchiaro J, Pikalov A, Kroger H, Loebel A.
    J Clin Psychiatry; 2015 Apr 01; 76(4):398-405. PubMed ID: 25844756
    [Abstract] [Full Text] [Related]

  • 17. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M, EMBOLDEN I (Trial 001) Investigators.
    J Clin Psychiatry; 2010 Feb 01; 71(2):150-62. PubMed ID: 20122369
    [Abstract] [Full Text] [Related]

  • 18. Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A, Cucchiaro J, Silva R, Kroger H, Hsu J, Sarma K, Sachs G.
    Am J Psychiatry; 2014 Feb 01; 171(2):160-8. PubMed ID: 24170180
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study.
    DelBello MP, Goldman R, Phillips D, Deng L, Cucchiaro J, Loebel A.
    J Am Acad Child Adolesc Psychiatry; 2017 Dec 01; 56(12):1015-1025. PubMed ID: 29173735
    [Abstract] [Full Text] [Related]

  • 20. C-reactive protein and response to lurasidone in patients with bipolar depression.
    Raison CL, Pikalov A, Siu C, Tsai J, Koblan K, Loebel A.
    Brain Behav Immun; 2018 Oct 01; 73():717-724. PubMed ID: 30102967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.